Clinical Trial: Effects of Remimazolam and Ciprofol TIVA on PRAE in Pediatric Tonsillectomy and Adenoidectomy

U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07118579) titled 'Effects of Remimazolam and Ciprofol TIVA on PRAE in Pediatric Tonsillectomy and Adenoidectomy' on Aug. 05.

Brief Summary: To observe the effects of remimazolam versus ciprofol TIVA on PRAE in pediatric tonsillectomy and adenoidectomy.

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Tonsillectomy With or Without Adenoidectomy

Intervention: DRUG: Remimazolam

remimazolam induction (0.3-0.5 mg/kg) + maintenance (1-3 mg/kg/h)

DRUG: Propofol

Anesthesia induction (2-3 mg/kg) + Anesthesia maintenance (6-10 mg/kg/h)

DRUG: Ciprofol

Anesthesia induction (0.4-0.5 mg/kg) + Anesthesia maintenance (0.8-1.2 mg/kg/h)

R...